Public Health Risks of Enterobacterial Isolates Producing Extended-Spectrum -Lactamases or AmpC -Lactamases in Food and Food-Producing Animals: An EU Perspective of Epidemiology, Analytical Methods, Risk Factors, and Control Options
E. Liébana(European Food Safety Authority), John Threlfall, Dik Mevius(Utrecht University), Alessandra Carattoli(Sapienza University of Rome), Teresa M. Coque(Instituto Cajal), Cármen Torres(Universidad de La Rioja), Karolina Törneke(Medical Products Agency), Luísa Maria Sobreira Vieira Peixe(Universidade do Porto), Henrik Hasman(Statens Serum Institut), J. Torren‐Edo, Laurent Poirel(University of Fribourg), Anna-Pelagia Magiorakos(European Centre for Disease Prevention and Control)
Cited by 254
Related Papers
Defining and combating antibiotic resistance from One Health and Global Health perspectives
|Nature Microbiology|2019|1.2k
The CTX-M β-lactamase pandemic
|Current Opinion in Microbiology|2006|1.1k
What is a resistance gene? Ranking risk in resistomes
|Nature Reviews Microbiology|2014|1k
CTX-M: changing the face of ESBLs in Europe
|Journal of Antimicrobial Chemotherapy|2006|923
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
|Eurosurveillance|2008|800